INR 3.6
(1.98%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 14.68 Million INR | -10.23% |
2022 | 16.36 Million INR | -43.37% |
2021 | 28.88 Million INR | 167.22% |
2020 | 10.81 Million INR | 5.77% |
2019 | 10.22 Million INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q3 | 3.48 Million INR | -30.55% |
2023 Q4 | 2.32 Million INR | -33.21% |
2023 FY | - INR | 3.91% |
2023 Q2 | 5.01 Million INR | 0.0% |
2023 Q1 | 5.01 Million INR | -1.28% |
2022 Q4 | 5.08 Million INR | 11.68% |
2022 FY | - INR | -43.37% |
2022 Q3 | 4.55 Million INR | 77.22% |
2022 Q2 | 2.56 Million INR | 0.0% |
2022 Q1 | 2.56 Million INR | 0.0% |
2021 FY | - INR | 167.22% |
2020 FY | - INR | 5.77% |
2019 FY | - INR | 0.0% |
2018 FY | - INR | 0.0% |
2017 FY | - INR | 0.0% |
2016 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 36.55 Million INR | 59.825% |
Checkpoint Trends Limited | 297.07 Thousand INR | -4843.953% |
Everest Organics Limited | 118.72 Million INR | 87.63% |
GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | -1295.268% |
NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | -392.532% |
Rajnish Wellness Limited | 19.93 Million INR | 26.34% |
Rama Vision Limited | 67.79 Million INR | 78.336% |
Vivo Bio Tech Limited | 212.99 Million INR | 93.105% |